Clinical Trials in Bern, Canton of Bern
20 recruiting
Showing 1–20 of 20 trials
Recruiting
Phase 3
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Relapsed or Refractory Multiple Myeloma (RRMM)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company440 enrolled138 locationsNCT06615479
Recruiting
Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Hematologic MalignanciesWaldenstroms MacroglobulinaemiaNon-Hodgkins Lymphoma+1 more
Merck Sharp & Dohme LLC490 enrolled121 locationsNCT04728893
Recruiting
Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery
Diabetes Mellitus, Type 1Energy Metabolism
Lia Bally40 enrolled1 locationNCT07478211
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Merck Sharp & Dohme LLC1,200 enrolled497 locationsNCT06430801
Recruiting
Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Non-small Cell Lung CancerCarcinoma, Non-Small Cell LungCarcinoma, Non-Small-Cell Lung (NSCLC)
Pfizer714 enrolled315 locationsNCT06758401
Recruiting
Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled70 locationsNCT07044297
Recruiting
Phase 3
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled188 locationsNCT07028853
Recruiting
Phase 2Phase 3
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
Pancreatic Ductal Adenocarcinoma
Bristol-Myers Squibb470 enrolled277 locationsNCT07076121
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 2
Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
GlioblastomaRecurrence Tumor
Centre Hospitalier Universitaire Vaudois59 enrolled7 locationsNCT07263438
Recruiting
BrainAgeMS - a Comparative Study of Brain Aging in Healthy and Patients With Multiple Sclerosis
Multiple Sclerosis
Insel Gruppe AG, University Hospital Bern200 enrolled1 locationNCT06221631
Recruiting
Phase 2
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Acute Lymphoblastic Leukemia
Pfizer100 enrolled74 locationsNCT05748171
Recruiting
Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Melanoma Stage IIIBMelanoma Stage IIICMelanoma Stage IIID
Philogen S.p.A.186 enrolled37 locationsNCT03567889
Recruiting
Not Applicable
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
Glottis TumorLarynx Cancer
Olgun Elicin34 enrolled4 locationsNCT04057209
Recruiting
Phase 1Phase 2
Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
LeukemiaNewly DiagnosedMyeloid+1 more
Molecular Partners AG249 enrolled9 locationsNCT05673057
Recruiting
Not Applicable
The Brain-Heart-Gut Connection
Major DepressionFunctional DyspepsiaAutonomous Dysfunction
University of Bern98 enrolled1 locationNCT06748274
Recruiting
Phase 2
Pharmacoscopy-guided Clinical Standard-of-care in r/r AML
AML, Adult
ETH Zurich88 enrolled2 locationsNCT06138990
Recruiting
Swiss Multiple Sclerosis Cohort-Study
Multiple Sclerosis
University Hospital, Basel, Switzerland1,200 enrolled8 locationsNCT02433028
Recruiting
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
FatigueMultiple SclerosisHypogammaglobulinemia
Insel Gruppe AG, University Hospital Bern106 enrolled1 locationNCT05357781
Recruiting
Phase 2
PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)
LymphomaLeukemiaMyeloma
Insel Gruppe AG, University Hospital Bern100 enrolled1 locationNCT06430736